Barclays analyst Jeffrey Bernstein downgraded Bloomin’ Brands (BLMN) to Equal Weight from Overweight with a price target of $13, down from $19. The firm expects the company to guide comp growth in the very low single-digit range for 2025, saying it is at risk of another negative year, while unit growth is expected to remain flattish. This will supports low-single-digit revenue growth at best, the analyst tells investors in a research note. With large comp headwinds, unit growth lacking, and limited earnings leverage, the shares will continue to underperform in 2025, contends Barclays.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BLMN:
- Bloomin’ Brands initiated with a Sell at Goldman Sachs
- Cigna drops pursuit of Humana: Morning Buzz
- Pinterest, Cisco upgraded: Wall Street’s top analyst calls
- Raymond James downgrades Bloomin’ on ‘underwhelming’ stake sale
- Bloomin’ Brands price target lowered to $16 from $20 at Piper Sandler
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
